Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208130 · ClinicalTrials.gov registry record · Phase 4
Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians
A Phase 4 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00208130 is a Phase 4 study that has completed, run by Creighton University. The registered enrollment target is 60 participants.
The verdict
NCT00208130, a Phase 4 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary objective of this study is to investigate the safety and efficacy of topiramate in the treatment of PTSD in women survivors of domestic violence and/or rape trauma as measured by the Clinician-Administered PTSD Scale (CAPS) for DSM-IV.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2001-10 |
| Est. Completion | 2004-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208130
The ClinicalTrials.gov registry entry for NCT00208130 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00208130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208130 about?
NCT00208130 is a clinical study titled "Topiramate in the Treatment of Posttraumatic Stress Disorder in Civilians". The primary objective of this study is to investigate the safety and efficacy of topiramate in the treatment of PTSD in women survivors of domestic violence and/or rape trauma as measured by the Clinician-Administered PTSD Scale (CAPS) for DSM-IV.
What is the current status of trial NCT00208130?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2001-10. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00208130?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00208130?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.